Coloplast A/S (CBHD) Stock Forecast & Price Target

Compare

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CBHD Analyst Ratings

Hold

3 Buy

6 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Coloplast

A/S

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CBHD Stock 12 Month Forecast

Average Price Target

CHF86.77

▼(-12.45% Downside)

Based on 10 Wall Street analysts offering 12 month price targets for Coloplast A/S in the last 3 months. The average price target is CHF86.77 with a high forecast of CHF100.19 and a low forecast of CHF73.26. The average price target represents a -12.45% change from the last price of CHF99.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"72":"CHF72","101":"CHF101","79.25":"CHF79.3","86.5":"CHF86.5","93.75":"CHF93.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":100.19056,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF100.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":86.76502496,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF86.77</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":73.264347,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF73.26</span>\n  </div></div>","useHTML":true}}],"tickPositions":[72,79.25,86.5,93.75,101],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,99.104,99.18758153846154,99.27116307692307,99.35474461538462,99.43832615384615,99.52190769230769,99.60548923076924,99.68907076923077,99.77265230769231,99.85623384615386,99.93981538461539,100.02339692307693,100.10697846153846,{"y":100.19056,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,99.104,98.15484807384615,97.20569614769231,96.25654422153846,95.30739229538462,94.35824036923077,93.40908844307693,92.45993651692308,91.51078459076923,90.56163266461539,89.61248073846154,88.6633288123077,87.71417688615385,{"y":86.76502496,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,99.104,97.11633438461539,95.12866876923077,93.14100315384616,91.15333753846154,89.16567192307693,87.1780063076923,85.1903406923077,83.20267507692307,81.21500946153846,79.22734384615384,77.23967823076923,75.25201261538461,{"y":73.264347,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":99.104,"date":1725148800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.104,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF100.19

Average Price TargetCHF86.77

Lowest Price TargetCHF73.26

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lisa Bedell Clive

Bernstein

CHF98.93→CHF95.17

Buy

-3.96%

Downside

Reiterated

09/11/25

Bernstein Remains a Buy on Coloplast A/S (0QBO)Bernstein SocGen Group analyst Lisa Bedell Clive lowered the price target on Coloplast A/S (COLOB:DC) (OTC: CLPBY) to DKK760.00 (from DKK790.00) while maintaining an Outperform rating.

Maja Pataki

Kepler Capital

CHF83.9

Hold

-15.34%

Downside

Reiterated

09/10/25

Coloplast A/S (0QBO) Receives a Hold from Kepler Capital

Falko Friedrichs

Deutsche Bank

CHF88.66→CHF82.65

Hold

-16.60%

Downside

Reiterated

09/08/25

Deutsche Bank Keeps Their Hold Rating on Coloplast A/S (0QBO)

Sam England

Berenberg Bank

CHF87.66→CHF81.4

Hold

-17.86%

Downside

Reiterated

09/05/25

Coloplast A/S (0QBO) Gets a Hold from Berenberg Bank

Hassan Al-Wakeel

Barclays

CHF92.67→CHF91.41

Hold

-7.76%

Downside

Reiterated

09/03/25

Barclays Remains a Hold on Coloplast A/S (0QBO)

Graham Doyle

UBS

CHF86.41→CHF76.76

Hold

-22.54%

Downside

Reiterated

08/28/25

UBS Reaffirms Their Hold Rating on Coloplast A/S (0QBO)

Jack Reynolds-Clark

RBC Capital

CHF87.66→CHF88.91

Hold

-10.28%

Downside

Reiterated

08/22/25

RBC Capital Remains a Hold on Coloplast A/S (0QBO)

Aisyah Noor

Morgan Stanley

CHF75.13→CHF73.26

Sell

-26.08%

Downside

Reiterated

08/20/25

Coloplast A/S (0QBO) Receives a Sell from Morgan Stanley

Julien Dormois

Jefferies

CHF106.44→CHF100.18

Buy

1.09%

Upside

Reiterated

08/20/25

Jefferies Keeps Their Buy Rating on Coloplast A/S (0QBO)

Unknown Analyst

Jyske Bank

Not Ranked

Jyske Bank

CHF93.92

Buy

-5.23%

Downside

Upgraded

07/08/25

Positive Report for Coloplast A/S (0QBO) from Jyske Bank

Veronika Dubajova

Citi

CHF110.2→CHF87.66

Hold

-11.55%

Downside

Reiterated

06/05/25

Citi Sticks to Its Hold Rating for Coloplast A/S (0QBO)

Shubhangi Gupta

HSBC

CHF107.69→CHF83.9

Hold

-15.34%

Downside

Downgraded

05/15/25

HSBC Downgrades Coloplast A/S (COLOB:DC) (CLPBY) to HoldHSBC analyst Shubhangi Gupta downgraded Coloplast A/S (COLOB:DC) (OTC: CLPBY) from Buy to Hold with a price target of DKK670.00 (from DKK860.00).

Anchal Verma

J.P. Morgan

CHF87.66→CHF80.14

Hold

-19.13%

Downside

Reiterated

05/07/25

Coloplast A/S (COLOB:DC) (CLPBY) PT Lowered to DKK640 at JPMorganJPMorgan analyst Anchal Verma lowered the price target on Coloplast A/S (COLOB:DC) (OTC: CLPBY) to DKK640.00 (from DKK700.00) while maintaining a Neutral rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lisa Bedell Clive

Bernstein

CHF98.93→CHF95.17

Buy

-3.96%

Downside

Reiterated

09/11/25

Maja Pataki

Kepler Capital

CHF83.9

Hold

-15.34%

Downside

Reiterated

09/10/25

Coloplast A/S (0QBO) Receives a Hold from Kepler Capital

Falko Friedrichs

Deutsche Bank

CHF88.66→CHF82.65

Hold

-16.60%

Downside

Reiterated

09/08/25

Deutsche Bank Keeps Their Hold Rating on Coloplast A/S (0QBO)

Sam England

Berenberg Bank

CHF87.66→CHF81.4

Hold

-17.86%

Downside

Reiterated

09/05/25

Coloplast A/S (0QBO) Gets a Hold from Berenberg Bank

Hassan Al-Wakeel

Barclays

CHF92.67→CHF91.41

Hold

-7.76%

Downside

Reiterated

09/03/25

Barclays Remains a Hold on Coloplast A/S (0QBO)

Graham Doyle

UBS

CHF86.41→CHF76.76

Hold

-22.54%

Downside

Reiterated

08/28/25

UBS Reaffirms Their Hold Rating on Coloplast A/S (0QBO)

Jack Reynolds-Clark

RBC Capital

CHF87.66→CHF88.91

Hold

-10.28%

Downside

Reiterated

08/22/25

RBC Capital Remains a Hold on Coloplast A/S (0QBO)

Aisyah Noor

Morgan Stanley

CHF75.13→CHF73.26

Sell

-26.08%

Downside

Reiterated

08/20/25

Coloplast A/S (0QBO) Receives a Sell from Morgan Stanley

Julien Dormois

Jefferies

CHF106.44→CHF100.18

Buy

1.09%

Upside

Reiterated

08/20/25

Jefferies Keeps Their Buy Rating on Coloplast A/S (0QBO)

Unknown Analyst

Jyske Bank

Not Ranked

Jyske Bank

CHF93.92

Buy

-5.23%

Downside

Upgraded

07/08/25

Positive Report for Coloplast A/S (0QBO) from Jyske Bank

Veronika Dubajova

Citi

CHF110.2→CHF87.66

Hold

-11.55%

Downside

Reiterated

06/05/25

Citi Sticks to Its Hold Rating for Coloplast A/S (0QBO)

Shubhangi Gupta

HSBC

CHF107.69→CHF83.9

Hold

-15.34%

Downside

Downgraded

05/15/25

Anchal Verma

J.P. Morgan

CHF87.66→CHF80.14

Hold

-19.13%

Downside

Reiterated

05/07/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Coloplast A/S

1 Month

xxx

Success Rate

2/6 ratings generated profit

Average Return

+0.27%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +0.27% per trade.

3 Months

xxx

Success Rate

6/6 ratings generated profit

Average Return

+6.93%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +6.93% per trade.

1 Year

Aisyah NoorMorgan Stanley

Success Rate

6/6 ratings generated profit

Average Return

+13.72%

reiterated a sell rating last month

Copying Aisyah Noor's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +13.72% per trade.

2 Years

xxx

Success Rate

6/6 ratings generated profit

Average Return

+13.72%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +13.72% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CBHD Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CBHD has received 5 Buy Ratings, 11 Hold Ratings, and 1 Sell Ratings. CBHD average Analyst price target in the past 3 months is 86.77.

Each month's total comprises the sum of three months' worth of ratings.

CBHD Financial Forecast

CBHD Earnings Forecast

Next quarter’s earnings estimate for CBHD is CHF0.83 with a range of CHF0.49 to CHF1.43. The previous quarter’s EPS was CHF0.48. CBHD beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year CBHD has Preformed in-line its overall industry.

CBHD Sales Forecast

Next quarter’s sales forecast for CBHD is CHF889.63M with a range of CHF870.81M to CHF907.26M. The previous quarter’s sales results were CHF871.56M. CBHD beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 55.07% of the time in the same period. In the last calendar year CBHD has Outperformed its overall industry.

CBHD Stock Forecast FAQ

What is CH:CBHD’s average 12-month price target, according to analysts?

Based on analyst ratings, Coloplast A/S’s 12-month average price target is 86.77.

What is CH:CBHD’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:CBHD, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Coloplast A/S a Buy, Sell or Hold?

Coloplast A/S has a consensus rating of Hold, which is based on 3 buy ratings, 6 hold ratings and 1 sell ratings.

What is Coloplast A/S’s share price target?

The average share price target for Coloplast A/S is 86.77. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF100.19 ,and the lowest forecast is CHF73.26. The average share price target represents -12.45% Decrease from the current price of CHF99.1.

What do analysts say about Coloplast A/S?

Coloplast A/S’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Coloplast A/S?

To buy shares of CH:CBHD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Coloplast A/S (CBHD) Stock Forecast & Price Target

CBHD Analyst Ratings

CBHD Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Coloplast A/S

CBHD Analyst Recommendation Trends

CBHD Financial Forecast

CBHD Earnings Forecast

CBHD Sales Forecast

CBHD Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts